The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

Even before the F.D.A. approval, some doctors have been prescribing weight loss drugs to people with sleep apnea. The F.D.A.’s decision may place added pressure on insurance companies to cover ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday ... which had Zepbound approved as a weight-loss drug last year.

ABC News chief medical correspondent Dr. Jen Ashton talks about how drugs commonly used for weight loss could help those suffering from sleep apnea. Prescriptions for GLP-1 weight loss medications ...

The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said ...

The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...

Tirzepatide is also the compound in the diabetes drug Mounjaro. Advertising Even before the FDA approval, some doctors have ...

Obstructive sleep apnea occurs when a person’s upper ... Medicare does not cover weight-loss drugs specifically for obesity, although the medications can be covered for conditions exacerbated ...

“This is a major step forward for patients with obstructive sleep apnea,” Dr. Sally Seymour ... which doesn’t cover drugs solely for weight loss. Without insurance coverage, Zepbound ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The ...